Skip to main content
Clinical Trials/NCT05418790
NCT05418790WithdrawnNot Applicable

A Pilot Study to Evaluate Alternative Viral Load Tests During Start of Antiretroviral Therapy in Persons Living With HIV: Reliability and Acceptability of Home Test Measures

Luis Montaner0 sites15 target enrollmentStarted: June 1, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Withdrawn
Sponsor
Enrollment
15
Primary Endpoint
Reliability and Accuracy

Study Overview

Brief Summary

A pilot study of alternative viral load testing with samples collected in the clinic and at home compared to traditional viral load monitoring in participants engaged in HIV care. Approximately 15 participants starting ART, or working to suppress a detectable viral load, will monitor viral loads during regular clinic appointments and in intermediate time-points during their participation in this pilot study.

Detailed Description

A pilot study of alternative viral load testing with samples collected in the clinic and at home compared to traditional viral load monitoring in participants engaged in HIV care. Approximately 15 participants starting ART, or working to suppress a detectable viral load, will monitor viral loads during regular clinic appointments and in intermediate time-points during their participation in this pilot study.

There are three planned research viral load evaluations in the trial, which may include but are not limited to the evaluations listed below:

  1. CLINICAL CARE VIRAL LOAD - This will take place at the clinic during the regular clinical follow-up to confirm effective viral suppression.. During these visits an HIV viral load sample will be collected using traditional venipuncture methods and analyzed using a qualified commercial test. These plasma values may be used as a comparator with other viral load test results.
  2. CLINIC TASSO COLLECTION - Participants will collect one or more Tasso device specimen(s) during in-clinic study visits. The main objective of these measurements is to evaluate HIV viral load monitoring using novel collection approaches with the supervision of trained study staff to minimize user error potential.
  3. HOME TASSO COLLECTION - Participants will be provided with Tasso devices to use at home in between regular parent study visits. These devices will be shipped in real-time to Wistar Institute for archiving before HIV viral loads will be measured. The main objective of these measurements is to evaluate the feasibility HIV viral load monitoring using novel collection approaches at home.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Device Feasibility
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Persons living with HIV starting an ART regimen or working to suppress a previously detectable viral load ≥ 5,000 copies/mL

Exclusion Criteria

  • Persons living with HIV suppressed on ART regimen.

Arms & Interventions

TASSO device

Experimental

During this trial, participants will have approximately 15 TASSO collection dates between in clinic and at home.

Intervention: TASSO device (Device)

Outcomes

Primary Outcomes

Reliability and Accuracy

Time Frame: 12 months

Determine the reliability and accuracy of alternative viral load tests to detect changes in viral load in participants starting ART or working to resuppress a detectable viral load ≥ 5,000 copies/mL at last measurement.

Feasibility of implementing a home-based viral load test

Time Frame: 12 months

Determine the feasibility of implementing a home-based viral load test in the context of starting ART or working to resuppress a detectable viral load ≥10,0005,000 copies/mL at last measurement.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Luis Montaner
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Luis Montaner

Sponsor Investigator

The Wistar Institute

Similar Trials